HomeComparePTITF vs MRK

PTITF vs MRK: Dividend Comparison 2026

PTITF yields 4.06% · MRK yields 2.81%● Live data

vsPost on X →
After 10 years · $10,000 invested · DRIP enabled
🏆 PTITF wins by $1949.28M in total portfolio value
10 years
PTITF
PTITF
● Live price
4.06%
Share price
$0.13
Annual div
$0.01
5Y div CAGR
100%
Payout ratio
50%
After 10 yrs · $10,000 · DRIP
Portfolio value
$1949.34M
Annual income
$1,861,204,853.71
Full PTITF calculator →
MRK
Merck & Co. Inc.
● Live price
2.81%
Share price
$118.10
Annual div
$3.32
5Y div CAGR
32.7%
Payout ratio
50%
After 10 yrs · $10,000 · DRIP
Portfolio value
$57.7K
Annual income
$10,113.78
Full MRK calculator →

Portfolio growth — PTITF vs MRK

📍 PTITF pulled ahead of the other in Year 1

Annual dividend income

🛡️

Recession Test — Did They Cut Dividends?

How each stock treated shareholders during the 3 biggest crises of the last 20 years

Crisis PeriodPTITFMRK
2008–2009
GFC
— No data— No data
2020 Q1–Q2
COVID
— No data— No data
2022 Q4
Rate Hike
— No data— No data
Based on dividend payment history. "Increased" = dividend grew during crisis. "Maintained" = held within 3%. "Cut" = reduced by more than 3%.
📅

Dividend Calendar Overlap

Combined, PTITF + MRK cover 0 of 12 monthsgood coverage

Jan
Feb
Mar
Apr
May
Jun
Jul
Aug
Sep
Oct
Nov
Dec
PTITF pays
MRK pays
Both pay
Neither
💰

Tax Bracket Optimizer

Which stock is actually better after tax? Adjust your rate to find out.

PTITF
Annual income on $10K today (after 15% tax)
$344.84/yr
After 10yr DRIP, annual income (after tax)
$1,582,024,125.65/yr
MRK
Annual income on $10K today (after 15% tax)
$238.95/yr
After 10yr DRIP, annual income (after tax)
$8,596.71/yr
At 15% tax rate, PTITF beats the other by $1,582,015,528.94/year in after-tax income after 10 years on $10,000
⚖️

Lazy Portfolio Split Optimizer

What's the optimal mix of PTITF + MRK for your $10,000?

PTITF: 50%MRK: 50%
100% MRK50/50100% PTITF
Portfolio after 10yr
$974.70M
Annual income
$930,607,483.75/yr
Blended yield
95.48%
📊

Analyst Conviction Gap

Where Wall Street is most bullish on MRK right now

PTITF
No analyst data
Altman Z
1.4
Piotroski
6/9
MRK
Analyst Ratings
24
Buy
12
Hold
1
Sell
Consensus: Buy
Price Target
$128.54
+8.8% upside vs current
Range: $100.00 — $150.00
Altman Z
4.0
Piotroski
6/9
Analyst ratings via FMP. Altman Z-Score: >3.0 safe, 1.81–3.0 grey zone, <1.81 distress. Piotroski: 7–9 strong, 0–3 weak.
🏛️

Copy Congress — What Are Politicians Buying?

Senate & House STOCK Act disclosures (last 90 days)

PTITF buys
0
MRK buys
8
PoliticianChamberTickerTypeAmountDate
Josh Gottheimer🏢 House$MRK▲ Buy$1,001 - $15,0002026-02-04
Michael McCaul🏢 House$MRK▼ Sell$15,001 - $50,0002026-01-13
Gilbert Cisneros🏢 House$MRK▲ Buy$1,001 - $15,0002025-12-19
Julie Johnson🏢 House$MRK▼ Sell$1,001 - $15,0002025-12-18
Julie Johnson🏢 House$MRK▼ Sell$1,001 - $15,0002025-11-13
Ro Khanna🏢 House$MRK▼ Sell$1,001 - $15,0002025-09-29
Val Hoyle🏢 House$MRK▼ Sell$1,001 - $15,0002025-09-23
Marjorie Taylor Greene🏢 House$MRK▲ Buy$1,001 - $15,0002025-08-28
Julie Johnson🏢 House$MRK▼ Sell$1,001 - $15,0002025-08-14
Gilbert Cisneros🏢 House$MRK▲ Buy$1,001 - $15,0002025-08-05
STOCK Act mandates disclosure within 45 days of transaction. Data via FMP.Full tracker →
MetricPTITFMRK
Forward yield4.06%2.81%
Annual dividend / share$0.01$3.32
Payout ratio50%50%
1-year div growth0%0%
5-year div CAGR100%32.7%
Portfolio after 10y$1949.34M$57.7K
Annual income after 10y$1,861,204,853.71$10,113.78
Total dividends collected$1943.04M$29.8K
Payment frequencyquarterlyquarterly
SectorStockHealthcare

Year-by-year: PTITF vs MRK ($10,000, DRIP)

YearPTITF PortfolioPTITF Income/yrMRK PortfolioMRK Income/yrGap
1← crossover$11,511$811.40$11,213$373.04+$298.00PTITF
2$14,063$1,745.85$12,667$512.06+$1.4KPTITF
3$19,034$3,986.62$14,439$708.14+$4.6KPTITF
4$30,452$10,085.65$16,640$988.16+$13.8KPTITF
5$62,744$30,160.30$19,432$1,394.07+$43.3KPTITF
6$183,291$116,154.78$23,057$1,992.90+$160.2KPTITF
7$830,358$634,237.05$27,889$2,894.79+$802.5KPTITF
8$6,259,078$5,370,594.84$34,518$4,286.29+$6.22MPTITF
9$82,365,419$75,668,204.93$43,912$6,494.35+$82.32MPTITF
10$1,949,335,852$1,861,204,853.71$57,714$10,113.78+$1949.28MPTITF

PTITF vs MRK: Complete Analysis 2026

PTITFStock

PT Indosat Ooredoo Hutchison Tbk, together with its subsidiaries, provides telecommunication services in Indonesia. The company offers post-paid and prepaid products that include various data and mobile voice solutions on 2G, 3G, and 4G broadband cellular networks under the IM3 Ooredoo brand. It also provides international calls, international roaming, and fixed line services. In addition, the company offers IoT and M2M solutions; IT services through private data center and disaster recovery center; Internet connectivity and data communication services for corporate customers; satellite-based services, such as transponder leasing, VSAT services, and TV channels for TV; cloud-based service for business transformation; and voice services. It provides services under the Ooredoo brand name. The company was founded in 1967 and is based in Jakarta, Indonesia. PT Indosat Ooredoo Hutchison Tbk (IDX:ISAT) operates as a subsidiary of Ooredoo Hutchison Asia Pte. Ltd.

Full PTITF Calculator →

MRKHealthcare

Merck & Co., Inc. operates as a healthcare company worldwide. It operates through two segments, Pharmaceutical and Animal Health. The Pharmaceutical segment offers human health pharmaceutical products in the areas of oncology, hospital acute care, immunology, neuroscience, virology, cardiovascular, and diabetes, as well as vaccine products, such as preventive pediatric, adolescent, and adult vaccines. The Animal Health segment discovers, develops, manufactures, and markets veterinary pharmaceuticals, vaccines, and health management solutions and services, as well as digitally connected identification, traceability, and monitoring products. It serves drug wholesalers and retailers, hospitals, and government agencies; managed health care providers, such as health maintenance organizations, pharmacy benefit managers, and other institutions; and physicians and physician distributors, veterinarians, and animal producers. The company has collaborations with AstraZeneca PLC; Bayer AG; Eisai Co., Ltd.; Ridgeback Biotherapeutics; and Gilead Sciences, Inc. to jointly develop and commercialize long-acting treatments in HIV. Merck & Co., Inc. was founded in 1891 and is headquartered in Kenilworth, New Jersey.

Full MRK Calculator →
📬

Get this PTITF vs MRK comparison by email

Save your analysis + weekly dividend insights. Free forever.

More comparisons

PTITF vs SCHDPTITF vs JEPIPTITF vs OPTITF vs KOPTITF vs MAINPTITF vs JNJPTITF vs ABBVPTITF vs PFE

⚠️ Educational purposes only. Not financial advice. Congressional trades sourced from SEC STOCK Act filings via FMP. Past performance does not guarantee future results.